Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy
In brief
A randomised clinical trial comparing platelet-rich plasma (PRP), made with a refined manual preparation method, against hyaluronic acid in knee osteoarthritis over a year. The authors report better pain, function and walking results and lower inflammation markers with PRP, and argue that delivering a sufficiently high total platelet count is key to lasting benefit.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy Authors: Himanshu Bansal, Jerry Leon, Jeremy L. Pont, David A. Wilson, Anupama Bansal, Diwaker Agarwal & Iustin Preoteasa Link: https://search.app/9ewKvjSuZqi7s4Vu7 Year of Publication: 2021
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

